3 | SEC Filings Hub

Filing metadata

Accession number: 0001140361-21-016016
Form type: Form 3
Filer: Ernexa Therapeutics Inc.
CIK: CIK 748592
Filed: May 05, 2021
Reporting period: May 01, 2021
Description: Initial ownership

Documents

0001140361-21-016016-index.htm

Complete submission

0001140361-21-016016.txt

directory listing

Filed by

Ernexa Therapeutics Inc.